Global Neuromyelitis Optica Therapy Market Size, Status and Forecast 2024-2031

Report ID: 922358 | Published Date: Sep 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Glucocorticoids
        1.2.3 Immunotherapies
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Neuromyelitis Optica Therapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Acute Attack
        1.3.3 Remission Prophylactic Treatment
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Neuromyelitis Optica Therapy Market Perspective (2016-2027)
    2.2 Neuromyelitis Optica Therapy Growth Trends by Regions
        2.2.1 Neuromyelitis Optica Therapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Neuromyelitis Optica Therapy Historic Market Share by Regions (2016-2021)
        2.2.3 Neuromyelitis Optica Therapy Forecasted Market Size by Regions (2022-2027)
    2.3 Neuromyelitis Optica Therapy Industry Dynamic
        2.3.1 Neuromyelitis Optica Therapy Market Trends
        2.3.2 Neuromyelitis Optica Therapy Market Drivers
        2.3.3 Neuromyelitis Optica Therapy Market Challenges
        2.3.4 Neuromyelitis Optica Therapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Neuromyelitis Optica Therapy Players by Revenue
        3.1.1 Global Top Neuromyelitis Optica Therapy Players by Revenue (2016-2021)
        3.1.2 Global Neuromyelitis Optica Therapy Revenue Market Share by Players (2016-2021)
    3.2 Global Neuromyelitis Optica Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Neuromyelitis Optica Therapy Revenue
    3.4 Global Neuromyelitis Optica Therapy Market Concentration Ratio
        3.4.1 Global Neuromyelitis Optica Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neuromyelitis Optica Therapy Revenue in 2020
    3.5 Neuromyelitis Optica Therapy Key Players Head office and Area Served
    3.6 Key Players Neuromyelitis Optica Therapy Product Solution and Service
    3.7 Date of Enter into Neuromyelitis Optica Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Neuromyelitis Optica Therapy Breakdown Data by Type
    4.1 Global Neuromyelitis Optica Therapy Historic Market Size by Type (2016-2021)
    4.2 Global Neuromyelitis Optica Therapy Forecasted Market Size by Type (2022-2027)

5 Neuromyelitis Optica Therapy Breakdown Data by Application
    5.1 Global Neuromyelitis Optica Therapy Historic Market Size by Application (2016-2021)
    5.2 Global Neuromyelitis Optica Therapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Neuromyelitis Optica Therapy Market Size (2016-2027)
    6.2 North America Neuromyelitis Optica Therapy Market Size by Type
        6.2.1 North America Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
        6.2.2 North America Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
        6.2.3 North America Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
    6.3 North America Neuromyelitis Optica Therapy Market Size by Application
        6.3.1 North America Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
        6.3.2 North America Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
        6.3.3 North America Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
    6.4 North America Neuromyelitis Optica Therapy Market Size by Country
        6.4.1 North America Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
        6.4.2 North America Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Neuromyelitis Optica Therapy Market Size (2016-2027)
    7.2 Europe Neuromyelitis Optica Therapy Market Size by Type
        7.2.1 Europe Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
        7.2.2 Europe Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
        7.2.3 Europe Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
    7.3 Europe Neuromyelitis Optica Therapy Market Size by Application
        7.3.1 Europe Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
        7.3.2 Europe Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
        7.3.3 Europe Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
    7.4 Europe Neuromyelitis Optica Therapy Market Size by Country
        7.4.1 Europe Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
        7.4.2 Europe Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size (2016-2027)
    8.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type
        8.2.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application
        8.3.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region
        8.4.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Neuromyelitis Optica Therapy Market Size (2016-2027)
    9.2 Latin America Neuromyelitis Optica Therapy Market Size by Type
        9.2.1 Latin America Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
        9.2.2 Latin America Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
        9.2.3 Latin America Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
    9.3 Latin America Neuromyelitis Optica Therapy Market Size by Application
        9.3.1 Latin America Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
        9.3.2 Latin America Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
        9.3.3 Latin America Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
    9.4 Latin America Neuromyelitis Optica Therapy Market Size by Country
        9.4.1 Latin America Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
        9.4.2 Latin America Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size (2016-2027)
    10.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type
        10.2.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application
        10.3.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country
        10.4.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Neuromyelitis Optica Therapy Introduction
        11.1.4 Pfizer Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Fresenius
        11.2.1 Fresenius Company Details
        11.2.2 Fresenius Business Overview
        11.2.3 Fresenius Neuromyelitis Optica Therapy Introduction
        11.2.4 Fresenius Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.2.5 Fresenius Recent Development
    11.3 Teva
        11.3.1 Teva Company Details
        11.3.2 Teva Business Overview
        11.3.3 Teva Neuromyelitis Optica Therapy Introduction
        11.3.4 Teva Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.3.5 Teva Recent Development
    11.4 Sandoz
        11.4.1 Sandoz Company Details
        11.4.2 Sandoz Business Overview
        11.4.3 Sandoz Neuromyelitis Optica Therapy Introduction
        11.4.4 Sandoz Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.4.5 Sandoz Recent Development
    11.5 Intas
        11.5.1 Intas Company Details
        11.5.2 Intas Business Overview
        11.5.3 Intas Neuromyelitis Optica Therapy Introduction
        11.5.4 Intas Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.5.5 Intas Recent Development
    11.6 Gyjtrs
        11.6.1 Gyjtrs Company Details
        11.6.2 Gyjtrs Business Overview
        11.6.3 Gyjtrs Neuromyelitis Optica Therapy Introduction
        11.6.4 Gyjtrs Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.6.5 Gyjtrs Recent Development
    11.7 NANG KUANG
        11.7.1 NANG KUANG Company Details
        11.7.2 NANG KUANG Business Overview
        11.7.3 NANG KUANG Neuromyelitis Optica Therapy Introduction
        11.7.4 NANG KUANG Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.7.5 NANG KUANG Recent Development
    11.8 Tianjin Kingyork
        11.8.1 Tianjin Kingyork Company Details
        11.8.2 Tianjin Kingyork Business Overview
        11.8.3 Tianjin Kingyork Neuromyelitis Optica Therapy Introduction
        11.8.4 Tianjin Kingyork Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.8.5 Tianjin Kingyork Recent Development
    11.9 Baxter
        11.9.1 Baxter Company Details
        11.9.2 Baxter Business Overview
        11.9.3 Baxter Neuromyelitis Optica Therapy Introduction
        11.9.4 Baxter Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.9.5 Baxter Recent Development
    11.10 CSL
        11.10.1 CSL Company Details
        11.10.2 CSL Business Overview
        11.10.3 CSL Neuromyelitis Optica Therapy Introduction
        11.10.4 CSL Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.10.5 CSL Recent Development
    11.11 Grifols
        11.11.1 Grifols Company Details
        11.11.2 Grifols Business Overview
        11.11.3 Grifols Neuromyelitis Optica Therapy Introduction
        11.11.4 Grifols Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.11.5 Grifols Recent Development
    11.12 Octapharma
        11.12.1 Octapharma Company Details
        11.12.2 Octapharma Business Overview
        11.12.3 Octapharma Neuromyelitis Optica Therapy Introduction
        11.12.4 Octapharma Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.12.5 Octapharma Recent Development
    11.13 CBOP
        11.13.1 CBOP Company Details
        11.13.2 CBOP Business Overview
        11.13.3 CBOP Neuromyelitis Optica Therapy Introduction
        11.13.4 CBOP Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
        11.13.5 CBOP Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Glucocorticoids
    Table 3. Key Players of Immunotherapies
    Table 4. Key Players of Other
    Table 5. Global Neuromyelitis Optica Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Neuromyelitis Optica Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Neuromyelitis Optica Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Neuromyelitis Optica Therapy Market Share by Regions (2016-2021)
    Table 9. Global Neuromyelitis Optica Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Neuromyelitis Optica Therapy Market Share by Regions (2022-2027)
    Table 11. Neuromyelitis Optica Therapy Market Trends
    Table 12. Neuromyelitis Optica Therapy Market Drivers
    Table 13. Neuromyelitis Optica Therapy Market Challenges
    Table 14. Neuromyelitis Optica Therapy Market Restraints
    Table 15. Global Neuromyelitis Optica Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Neuromyelitis Optica Therapy Market Share by Players (2016-2021)
    Table 17. Global Top Neuromyelitis Optica Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromyelitis Optica Therapy as of 2020)
    Table 18. Ranking of Global Top Neuromyelitis Optica Therapy Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Neuromyelitis Optica Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Neuromyelitis Optica Therapy Product Solution and Service
    Table 22. Date of Enter into Neuromyelitis Optica Therapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2016-2021)
    Table 26. Global Neuromyelitis Optica Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Neuromyelitis Optica Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Neuromyelitis Optica Therapy Revenue Market Share by Application (2016-2021)
    Table 30. Global Neuromyelitis Optica Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Neuromyelitis Optica Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Neuromyelitis Optica Therapy Product
    Table 65. Pfizer Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 66. Pfizer Recent Development
    Table 67. Fresenius Company Details
    Table 68. Fresenius Business Overview
    Table 69. Fresenius Neuromyelitis Optica Therapy Product
    Table 70. Fresenius Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 71. Fresenius Recent Development
    Table 72. Teva Company Details
    Table 73. Teva Business Overview
    Table 74. Teva Neuromyelitis Optica Therapy Product
    Table 75. Teva Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 76. Teva Recent Development
    Table 77. Sandoz Company Details
    Table 78. Sandoz Business Overview
    Table 79. Sandoz Neuromyelitis Optica Therapy Product
    Table 80. Sandoz Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 81. Sandoz Recent Development
    Table 82. Intas Company Details
    Table 83. Intas Business Overview
    Table 84. Intas Neuromyelitis Optica Therapy Product
    Table 85. Intas Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 86. Intas Recent Development
    Table 87. Gyjtrs Company Details
    Table 88. Gyjtrs Business Overview
    Table 89. Gyjtrs Neuromyelitis Optica Therapy Product
    Table 90. Gyjtrs Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 91. Gyjtrs Recent Development
    Table 92. NANG KUANG Company Details
    Table 93. NANG KUANG Business Overview
    Table 94. NANG KUANG Neuromyelitis Optica Therapy Product
    Table 95. NANG KUANG Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 96. NANG KUANG Recent Development
    Table 97. Tianjin Kingyork Company Details
    Table 98. Tianjin Kingyork Business Overview
    Table 99. Tianjin Kingyork Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 100. Tianjin Kingyork Recent Development
    Table 101. Baxter Company Details
    Table 102. Baxter Business Overview
    Table 103. Baxter Neuromyelitis Optica Therapy Product
    Table 104. Baxter Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 105. Baxter Recent Development
    Table 106. CSL Company Details
    Table 107. CSL Business Overview
    Table 108. CSL Neuromyelitis Optica Therapy Product
    Table 109. CSL Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 110. CSL Recent Development
    Table 111. Grifols Company Details
    Table 112. Grifols Business Overview
    Table 113. Grifols Neuromyelitis Optica Therapy Product
    Table 114. Grifols Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 115. Grifols Recent Development
    Table 116. Octapharma Company Details
    Table 117. Octapharma Business Overview
    Table 118. Octapharma Neuromyelitis Optica Therapy Product
    Table 119. Octapharma Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 120. Octapharma Recent Development
    Table 121. CBOP Company Details
    Table 122. CBOP Business Overview
    Table 123. CBOP Neuromyelitis Optica Therapy Product
    Table 124. CBOP Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
    Table 125. CBOP Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuromyelitis Optica Therapy Market Share by Type: 2020 VS 2027
    Figure 2. Glucocorticoids Features
    Figure 3. Immunotherapies Features
    Figure 4. Other Features
    Figure 5. Global Neuromyelitis Optica Therapy Market Share by Application: 2020 VS 2027
    Figure 6. Acute Attack Case Studies
    Figure 7. Remission Prophylactic Treatment Case Studies
    Figure 8. Neuromyelitis Optica Therapy Report Years Considered
    Figure 9. Global Neuromyelitis Optica Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Neuromyelitis Optica Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Neuromyelitis Optica Therapy Market Share by Regions: 2020 VS 2027
    Figure 12. Global Neuromyelitis Optica Therapy Market Share by Regions (2022-2027)
    Figure 13. Global Neuromyelitis Optica Therapy Market Share by Players in 2020
    Figure 14. Global Top Neuromyelitis Optica Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromyelitis Optica Therapy as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Neuromyelitis Optica Therapy Revenue in 2020
    Figure 16. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2016-2021)
    Figure 17. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2022-2027)
    Figure 18. North America Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
    Figure 20. North America Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
    Figure 21. North America Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
    Figure 22. United States Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
    Figure 26. Europe Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
    Figure 27. Europe Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
    Figure 28. Germany Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Neuromyelitis Optica Therapy Market Share by Region (2016-2027)
    Figure 38. China Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
    Figure 46. Latin America Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
    Figure 47. Latin America Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
    Figure 48. Mexico Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
    Figure 54. Turkey Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Pfizer Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 58. Fresenius Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 59. Teva Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 60. Sandoz Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 61. Intas Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 62. Gyjtrs Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 63. NANG KUANG Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 64. Tianjin Kingyork Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 65. Baxter Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 66. CSL Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 67. Grifols Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 68. Octapharma Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 69. CBOP Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Fresenius
Teva
Sandoz
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
Frequently Asked Questions
Neuromyelitis Optica Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuromyelitis Optica Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuromyelitis Optica Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports